Interferon-α increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?

Tenoxicam, a non-steroid anti-inflammato

Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon

✍ Jean-Pierre Zarski; Marianne Maynard-Muet; Suzanne Chousterman; Maryline Baud; R 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

The purpose of this study is to compare a combination of interferon (IFN)-␣ 2 a (Roferon) ؉ Tenoxicam with IFN-␣ 2 a alone in the treatment of chronic hepatitis C. This prospective, randomized double-blind study included 149 patients, all of whom were diagnosed with active chronic hepatitis C but no